作者
James S Chavez, Jennifer L Rabe, Dirk Loeffler, Kelly C Higa, Giovanny Hernandez, Taylor S Mills, Nouraiz Ahmed, Rachel L Gessner, Zhonghe Ke, Beau M Idler, Katia E Niño, Hyunmin Kim, Jason R Myers, Brett M Stevens, Pavel Davizon-Castillo, Craig T Jordan, Hideaki Nakajima, John Ashton, Robert S Welner, Timm Schroeder, James DeGregori, Eric M Pietras
发表日期
2021/4/15
期刊
Journal of Experimental Medicine
卷号
218
期号
6
页码范围
e20201169
出版商
Rockefeller University Press
简介
Hematopoietic stem cells (HSCs) are capable of entering the cell cycle to replenish the blood system in response to inflammatory cues; however, excessive proliferation in response to chronic inflammation can lead to either HSC attrition or expansion. The mechanism(s) that limit HSC proliferation and expansion triggered by inflammatory signals are poorly defined. Here, we show that long-term HSCs (HSCLT) rapidly repress protein synthesis and cell cycle genes following treatment with the proinflammatory cytokine interleukin (IL)-1. This gene program is associated with activation of the transcription factor PU.1 and direct PU.1 binding at repressed target genes. Notably, PU.1 is required to repress cell cycle and protein synthesis genes, and IL-1 exposure triggers aberrant protein synthesis and cell cycle activity in PU.1-deficient HSCs. These features are associated with expansion of phenotypic PU.1-deficient …
引用总数
2020202120222023202411120229
学术搜索中的文章